fleroxacin has been researched along with Pneumonia, Bacterial in 2 studies
Fleroxacin: A broad-spectrum antimicrobial fluoroquinolone. The drug strongly inhibits the DNA-supercoiling activity of DNA GYRASE.
fleroxacin : A fluoroquinolone antibiotic that is 4-oxo-1,4-dihydroquinoline which is substituted at positions 1, 3, 6, 7 and 8 by 2-fluoroethyl, carboxy, fluoro, 4-methylpiperazin-1-yl and fluoro groups, respectively. It is active against many Gram-positive and Gram-negative bacteria.
Pneumonia, Bacterial: Inflammation of the lung parenchyma that is caused by bacterial infections.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The once daily dosage of fleroxacin [400 mg once daily intravenously (i." | 2.68 | Quinolones in everyday clinical practice: respiratory tract infections and nosocomial pneumonia. ( Marklein, G, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marklein, G | 1 |
| Ragnar Norrby, S | 1 |
2 trials available for fleroxacin and Pneumonia, Bacterial
| Article | Year |
|---|---|
Quinolones in everyday clinical practice: respiratory tract infections and nosocomial pneumonia.
Topics: Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Cross Infection; Double-Blind Method; Female; Fle | 1996 |
Atypical pneumonia in the Nordic countries: aetiology and clinical results of a trial comparing fleroxacin and doxycycline. Nordic Atypical Pneumonia Study Group.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Chlamydia Infections; Community-Acq | 1997 |